Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 5, 2026.

via HealthDay

TUESDAY, May 5, 2026 — U.S. Supreme Court Justice Samuel Alito Jr. issued an order Monday that allows patients to continue accessing abortion pill, mifepristone, by mail, for now.

The one-sentence order pauses a Friday ruling from the U.S. Court of Appeals for the Fifth Circuit in New Orleans that required an in-person pickup for mifepristone, according to The Washington Post.

If the lower court ruling holds, healthcare providers could no longer prescribe the drug through telehealth and ship it to their patients. Instead, patients would have to pick up the prescription from their healthcare provider — a past U.S. Food and Drug Administration (FDA) requirement that was lifted during the pandemic in 2021.

About one-fourth of abortions in the United States are now provided through telemedicine, according to The New York Times.

Danco Laboratories, maker of the drug, and GenBioPro, manufacturer of its generic version, requested the immediate pause from the lower court ruling — one Danco described in its appeal as "unprecedented," according to The Post.

“Never before has a federal court purported to immediately enjoin a several years’ old drug approval; restrict a distribution system for that drug that manufacturers, providers, patients, and pharmacies have all been using for years; or reinstate conditions that FDA determined do not meet the mandatory statutory criteria,” Danco wrote.

In its emergency filing, GenBioPro wrote: “The order is deeply unsettling to drug sponsors, healthcare providers, patients, and the public — all of whom rely on FDA’s exercise of scientific judgment and orderly administration of the Nation’s complex system of drug regulation."

The FDA is conducting a review of mifepristone, and the Trump administration had requested the lower court put the case on hold until that's finished.

The pause issued by Alito will last until at least May 11, according to The Times, when the full court will then determine how to move forward.

Sources

  • The Washington Post, May 4, 2026
  • The New York Times, May 4, 2026
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords